China's "Next New Three": How AI, Robotics, and Biopharma Are Redefining the Export Powerhouse

For two decades, the world knew China as the factory for everything from sneakers to smartphones. In recent years that identity narrowed around the "New Three"—electric vehicles, lithium batteries, and solar panels—which became the backbone of Chinese exports. Now, in 2026, a new chapter is opening, and Beijing's policymakers have a name for it: the "Next New Three."

The trio is artificial intelligence, robotics, and innovative drugs. Together they mark the most significant upgrade in China's industrial and export model since the country joined the global manufacturing mainstream. The shift is not cosmetic. It signals a move from exporting manufacturing capacity to exporting high-end innovation—original research, core technologies, and services rather than volume and cost.

The numbers tell the story. According to People's Daily, domestic large-language models registered 36.11 trillion token calls in the week of July 13–19 alone, up nearly 31% week-on-week and climbing for eight straight weeks. In the first half of 2026, China's robotics exports reached 6.29 billion yuan (about $929 million), reaching 141 countries and regions, with high-end surgical robots surging 3.3-fold year-on-year. The innovative-drug sector posted outbound technology-licensing deals totaling $110 billion in the first six months, and Chinese companies accounted for eight of the world's top ten pharma licensing deals.

What makes this wave different is how visibly it is going global. Four-legged inspection robots from Hangzhou-based DEEP Robotics are now deployed at Switzerland's Leibstadt Nuclear Power Plant, the country's largest, performing autonomous 24/7 inspections in high-risk zones. Shenzhen's DoBot ships coffee-making robotic arms to airports, rail stations, and malls across more than 20 venue types worldwide, with one Mediterranean installation serving drinks unmanned for Coca-Cola. iFLYTEK's AI teaching system is supporting Chinese-language education in Thai schools.

At home, the ecosystem is accelerating. In April 2026, Beijing's Yizhuang district hosted a humanoid-robot half-marathon—a symbolic moment for an embodied-AI sector that now counts more than 230 companies and over 400 whole-machine product releases. That same month, Beijing's first "token factory" opened in Yizhuang with phase-one daily capacity above 1.4 trillion tokens, designed to link with green-power bases in Zhangjiakou and Ulanqab toward a long-term target of 10 trillion tokens per day.

The macro backdrop matters. In the first half of 2026, Chinese exports of high-tech and high-value-added mechanical and electronic products reached 7.58 trillion yuan ($1.12 trillion), up 18.4% year-on-year, while shipments of green new-energy products—lithium batteries, solar panels, wind turbines—rose roughly 40%. The National Development and Reform Commission estimates that six emerging pillar industries (integrated circuits, aerospace, biomedicine, low-altitude economy, new storage, and smart robotics) were worth nearly 6 trillion yuan in 2025 and could exceed 10 trillion yuan by 2030.

The strategic implication is clear. While the "New Three" secure China's trade fundamentals, the "Next New Three" seize the commanding heights of future industries. For overseas readers, the takeaway is not just that Chinese products are improving—it's that the country is now exporting the software, robotics, and biotech that other nations will build their own industries on.